AMR

R&D

Gloved lab hand holds petri dish with AMR test

AI can help us build a new, more precise, antibiotic pipelin...

AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

R&D

Europe has the tools to fight superbugs. Let’s use them.

Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.

R&D

Why conditions like UTI call for new antibiotics

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

R&D

Why I'm focused on the trillion-dollar AMR crisis everyone's...

AMR demands sustained commitment beyond conventional market incentives.

R&D

When is the superbug message going to bite?

As existing antibiotics become less effective, we edge closer to a future where routine infections & minor injuries could once again become high risk.

AI can help us build a new, more precise, antibiotic pipelin...

EU invests €30m to fight antimicrobial resistance

Europe has the tools to fight superbugs. Let’s use them.

Why conditions like UTI call for new antibiotics

Why I'm focused on the trillion-dollar AMR crisis everyone's...

When is the superbug message going to bite?

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

AMR

Editor's Picks